KCNH2 and pancreatic neoplasm: For example, gemcitabine, commonly used in the treatment of pancreatic cancer and non-small cell lung cancer, may cause cardiotoxicity as it reduces the expression of Kv11.1 (human rapid delayed rectifier potassium channel, hERG).